Topic:Disease control
Disease control in horses encompasses the strategies and measures implemented to prevent, manage, and eradicate infectious and non-infectious diseases within equine populations. This field involves the study of pathogen transmission, host-pathogen interactions, and the development of effective vaccination and biosecurity protocols. Disease control also includes monitoring and surveillance of equine health to identify outbreaks and implement timely interventions. Key aspects of disease control in horses involve understanding the epidemiology of equine diseases, improving diagnostic techniques, and enhancing treatment options. This page compiles peer-reviewed research studies and scholarly articles that explore various methodologies, technologies, and practices aimed at controlling diseases in horses, with a focus on improving overall equine health and welfare.
Susceptibility of horses to Mycobacterium paratuberculosis. The susceptibility of horses to Mycobacterium paratuberculosis was studied. A total of 8 colts was used: 2 colts were exposed intravenously and 1 colt used as a contact control was placed with them; 2 colts were exposed intragastrically; 1 colt was administered killed M. paratuberculosis intravenously; and the remaining 2 colts were used as normal controls and were housed separately. Colts administered live bacilli intravenously began losing weight 84 days after exposure, and shortly thereafter they had clinical signs of disease, consisting of loss of body weight and rough coat. The exposed co...
Preparation and evaluation of inactivated Venezuelan equine encephalitis vaccines. No abstract available
Stability of live attenuated Venezuelan equine encephalitis vaccine. Reconstituted Venezulean equine encephalitis vaccine was found to retain significant titers of plaque-forming virus after storage at 4 or 22 C for 24 hr.
Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The highest level of viremia measured was 7 x 10(3) to 8 x 10(3) plaqueforming units per ml. No adverse reactions to the vaccine were observed in any horses, including 42 pregnant mares and their resulting foals.
Cases of equine coital exanthema in Denmark. A venereal disease usually designated equine coital exanthema (ECE) has been observed in horses all over the world. In a very few oases a virus, claimed to be the causative agent of the disease, has been isolated.